Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accommodate, accomplished, adequacy, adjudicating, aerobic, aerospace, ALIM, Alimera, allied, appellant, appellee, appendix, Arisaph, arithmetic, assimilate, AstraZeneca, AVDR, Avedro, aveo, bacteraemia, bad, Barr, Beach, biopharma, border, Bruce, Budgetary, Buffalo, bundle, CAH, cap, Cardinal, Carlo, CFO, Chair, channel, chargeback, cIAI, Circuit, circumvention, cliff, cloud, Commerce, Commerzbank, Commissioner, Commonwealth, condensed, constraint, consumption, contributory, CoreRx, corneal, costlier, counterparty, CPI, CTI, cybersecurity, Daemen, Deloitte, Dendreon, devise, disaggregation, dismissal, dismissed, dismissing, DNDN, DOC, Dornier, Downey, dramatically, DRG, Duke, EC, Edison, EEA, Emory, EndoChoice, enjoin, epidemiology, Evecxia, expiry, explanatory, explicitly, FFWK, FL, flux, forfeited, foundation, fresh, fundamental, GDPR, GI, goodwill, GPO, guest, Hackensack, Harvard, HealthQuest, heard, hefty, HHS, highest, Hofstra, home, HSGX, Iceland, iiii, Imaging, ImClone, ImmusanT, inaction, inadequacy, injured, insecurity, Interland, Intersouth, Jay, Jersey, Kos, landscape, lawyer, lecturer, left, LH, Liechtenstein, LLY, logo, LP, magnitude, mandated, Maximillian, MDCO, MelintAssist, membership, Memorial, Meridian, Metuchen, Miami, Milligan, mix, MNTA, Molecular, Momenta, momentum, Monte, moot, Morristown, NewSpring, NJ, nonrecurring, Nordisk, Novo, Novoste, NTAP, nursing, NxStage, NYSE, obsolescence, Ohio, Orchestra, outsourced, overriding, Overview, page, Palm, Park, Pathology, payer, Pearl, pecuniary, Pennsylvania, Peter, pharmacist, plc, Poison, Portola, possession, PPS, predominant, prepay, prerequisite, prompt, PTLA, Pure, pyrrolocytosine, qualification, reallocation, reciprocal, redemption, refund, regenerative, regime, repurchase, revisit, revocation, Road, Roswell, Royal, runway, sabotage, salesforce, Savient, SBBP, Schering, sector, Shaw, Shield, simulation, sit, skip, smooth, sNDA, Sofinnova, spent, SSKN, Stanford, store, Strata, strongbridge, Stroudsburg, Subtopic, SUNY, Symphony, SYNH, tender, Teva, therefrom, therewith, Touche, transaminase, transferee, Trust, turnover, TZYM, UK, undelivered, undiscounted, uniformed, unopened, usage, UTHR, vaborbactum, variation, VCM, venture, VHP, VHPM, view, Villanova, VIP, virtue, WACC, waived, Wake, Wako, Wharton, whichever, Whippany, Woodbridge, wrap, wrote, XBRL, XLS, YMCA
Removed:
abbreviated, achievable, acid, addressed, AEs, affiliated, Africa, altogether, American, ANDA, approving, attain, attestation, attributed, automatic, baseline, begun, bioavailability, blood, bone, bound, catastrophic, cGCP, choice, chronic, clinically, commencement, communication, confirm, consultation, correct, corroborated, Darussalam, deliverable, demonstrating, deployed, dissemination, dosage, drafted, element, enhanced, equally, essential, evaluable, exacerbate, expended, FDAAA, feel, fewer, fix, fusidic, identity, incurring, IND, innovator, Instruction, intentional, invoiced, IPO, irreversible, judicial, language, licensee, lost, lung, medication, moiety, molecule, panel, passed, pedigree, persuasive, Pharma, plant, precisely, preclude, preserve, procuring, produced, progressing, promoted, proportion, proven, published, pursued, randomization, reconsider, redeemable, refine, refractory, reinterpreted, representative, reviewing, signature, sponsored, staphylococcal, strictly, submitting, substance, suppressive, switching, targeting, television, toxicity, unannounced, uneven, unobservable, unsolicited, validated, withdrawn
Filing tables
Filing exhibits
Related press release
MLNTQ similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-221531, 333-219881, 333-204560, 333-190891, 333-181358, 333-227179 (including Post-Effective Amendment No. 1), 333-227180, and 333-228445 on Form S-8; and Registration Statement Nos. 333-222487, 333-222485, and 333-222731 on Form S-3; of our report dated March 13, 2019, relating to the financial statements of Melinta Therapeutics, Inc. and subsidiaries (which report expresses an unqualified opinion and includes an explanatory paragraph relating to uncertainty about the Company’s ability to continue as a going concern), appearing in this Annual Report on Form 10-K of Melinta Therapeutics, Inc. for the year ended December 31, 2018.
/s/ Deloitte & Touche LLP
Chicago, Illinois
March 13, 2019
March 13, 2019